Skip to main content
. 2023 Nov 15;11(11):e5403. doi: 10.1097/GOX.0000000000005403

Table 1.

Population Characteristics

Variable Total, N = 427 TXA IV, n = 208 TXA IV and Oral, n = 219 P
Age (y) 34 (28–42) 36 (29–43.5) 33 (27–41) 0.019
Weight (kg)
 No data, n (%)
65 (60–71)
4
65 (60–72)
1
64 (60–70)
3
0.187
BMI 0.069
 Normal 239 (56.5) 106 (51.2) 133 (61.6)
 Overweight 167 (39.5) 90 (43.5) 77 (35.6)
 Obese 17 (4.0) 11 (5.3) 6 (2.8)
ASA, n (%)* 0.151
 I 327 (76.6) 155 (74.5) 172 (78.5)
 II 91 (21.3) 51 (24.5) 40 (18.3)
 III 1 (0.2) 1 (0.5)
 No data, n (%) 8 (1.9) 2 (1.0) 6 (2.7)
Caprini score* 0.193
 2 20 (4.6) 5 (2.4) 15 (6.9)
 3 240 (56.2) 121 (58.2) 119 (54.3)
 4 95 (22.2) 49 (23.5) 46 (21.0)
 5 4 (0.9) 1 (0.5) 3 (1.4)
 No data, n (%) 68 (15.9) 32 (15.4) 36 (16.4)
Medications* 0.749
 Yes 2 (0.5) 207 (99.5) 216 (98.6)
 No 423 (99.0) 1 (0.5) 1 (0.5)
 No data, n (%) 2 (0.5) 2 (0.9)
Surgical procedure* 0.198
 Abdominoplasty 9 (2.1) 6 (2.9) 3 (1.4)
 Lipoabdominoplasty 91 (21.3) 51 (24.5) 40 (18.2)
 Liposuction 114 (26.7) 49 (23.6) 65 (29.7)
 Combined surgery, blepharoplasty, breast augmentation, breast lifting 213 (49.8) 102 (49.0) 111 (50.7)
Preoperative parenteral iron* 0.510
 Yes 17 (3.9) 8 (3.8) 9 (4.1)
 No 408 (95.6) 198 (95.2) 210 (95.9)
 No data, n (%) 2 (0.5) 2 (1.0)
Surgical values
 Infiltration (mL) 4000 (3300–5000) 4000 (3300–4900) 4000 (3400–5000) 0.889
  No data (n) 2 2
 Liposuctioned (mL) 3600 (2800–4700) 3650 (2700–4600) 3600 (2950–4800) 0.621
  No data (n) 5 2 3
 Time (min) 225 (180–266) 223.5 (173–269) 225 (181–264) 0.858
  No data (n) 62 30 32
 10-min wait 0.530
  Yes 275 (64.4) 139 (66.8) 136 (62.1)
  No 76 (17.8) 33 (15.9) 43 (19.6)
  No data (n) 76 (17.8) 36 (17.3) 40 (18.3)
 Pronation (min) 72 (57.5) 70 (55–90) 75 (60–90) 0.223
  No data (n) 47 20 27
Preoperative levels
 Hemoglobin (mg/dL) 13.7 (13.0–14.3) 13.6 (13.0–14.3) 13.7 (13.0–14.3) 0.913
*

Estimated difference with the Fisher exact test. Quantitative variables are reported as medians and interquartile range.

BMI, body mass index.